High Antitumor Activity of RLI, an Interleukin-15 (IL-15)-IL-15 Receptor Fusion Protein, in Metastatic Melanoma and Colorectal Cancer

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-0275
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)